Showing results (261-270 of 432) with videos related to

Sort By:
Pageof 44
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2014
Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie CellulaireGandhi Damaj, Mohammad Mohty, Marie Robin, et al.
Leukemia Research|February 29, 2016
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemiaJean-Baptiste Fraison, Arsène Mekinian, Eric Grignano, et al.
British Journal of Haematology|November 6, 2022
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registryKrzysztof Mądry, Karol Lis, Pierre Fenaux, et al.
Leukemia Research|December 20, 2014
Azacitidine for the treatment of relapsed and refractory AML in older patientsRaphael Itzykson, Sylvain Thépot, Céline Berthon, et al.
American Journal of Hematology|May 29, 2015
Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosisCharles Herbaux, Nicolas Duployez, Catherine Badens, et al.
Blood|May 20, 2006
High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2aJean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, et al.
Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.
Hematological Oncology|April 3, 2022
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignanciesTariq I Mughal, Naveen Pemmaraju, Rafael Bejar, et al.
Leukemia|June 24, 2025
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemiaDelphine Lebon, Audrey Da Rocha, Bruno Cassinat, et al.
Lancet (London, England)|April 10, 2012
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 studySylvie Castaigne, Cécile Pautas, Christine Terré, et al.
Pageof 44